Tag: Health Care

Displaying 541 - 560 of 840 results.

Commission approval of final consent orders: Following a public comment period, the Commission has approved a final consent order in the matter concerning the Virginia Board of Funeral Directors and Embalmers. The Commission vote to approve the final consent order and respond to the commenter of...
A consent order settled charges that the White Sands Health Care System refused to deal with health care insurers that resisted the collectively negotiated prices set by its member physicians and nurse anesthetists. The complaint alleged that these practices increased costs for...
A physician-hospital organization (PHO) in New Mexico has agreed to settle Federal Trade Commission charges that it drove up the cost of health care for consumers in the Alamogordo, NM area by jointly fixing prices charged by physicians and by nurse anesthetists to health plans and other payors....
In response to a request from California Assembly Member Greg Aghazarian, FTC staff have commented on a bill (AB 1960) that requires pharmacy benefit managers ("PBMs") to disclose certain information to purchasers and prospective purchasers of their services, as well as to prescribers and...
The Commission authorized staff to file a complaint in federal district court charging that Alpharma, Inc. and Perrigo Company drove up the prices for over-the-counter store-brand children’s liquid ibuprofen through an agreement eliminating competition between the two firms and...
Generic drug manufacturers Alpharma, Inc. and Perrigo Company will give up $6.25 million in illegal profits to settle Federal Trade Commission charges that their agreement to limit competition for over-the-counter (OTC) store-brand children’s liquid ibuprofen drove up prices and violated federal...
A North Carolina physician-hospital organization (PHO) and ten of its physician members have agreed to settle Federal Trade Commission charges that they fixed prices for the services of the PHO’s 450 physician members, hindered competition in four western North Carolina counties, and raised costs...
The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order...
  Under a consent agreement announced today, the Federal Trade Commission will allow Cephalon, Inc.’s $515 million acquisition of Cima Labs, Inc., provided that Cephalon grants Barr Laboratories, Inc. a fully paid-up, irrevocable license to manufacture and sell a generic formulation of Cephalon’s...
Commission authorization of staff amicus brief filing: The Commission has authorized the staff to file a joint amicus brief in Spano, et al. v. SAFECO Insurance Co. of America, et al., No 04-35313 (9th Cir.).
In a decision filed today, the Federal Trade Commission denied the motion of the South Carolina State Board of Dentistry to dismiss this action on the ground that its actions were protected by the state action doctrine. The Commission concluded that the Board’s “emergency regulation,” which...
The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order,...
Under the terms of a consent agreement announced today, the Federal Trade Commission would allow France’s Sanofi-Synthélabo’s (Sanofi) $64 billion acquisition of Aventis, provided the companies divest certain assets and royalty rights in the overlapping markets for factor Xa inhibitors used as...
Commission authorization of joint amicus brief filing: The Commission has authorized the filing of a joint amicus brief with the U.S. Department of Justice (DOJ) in Andrx Pharmaceuticals, Inc. v. Kroger Company, et al. (U.S. Court of Appeals for the Sixth Circuit). This case concerns a private...
Joint brief of the United States and the Federal Trade Commission, urging the Court to deny a writ of certiorari in this case, regarding private patent litigation and the legal standards applicable to “reverse payment” patent litigation settlements in the Hatch-Waxman context...
A Roswell, New Mexico physicians’ association, Southeastern New Mexico Physicians IPA, settled charges that it and two of its employees entered into collective agreements among physician members on fees and refused to deal with health plans that did not accept the collective agreed-...
  A Roswell, New Mexico-based physicians' association and two of its employees have agreed to settle Federal Trade Commission charges that they orchestrated agreements among Southeastern New Mexico Physicians IPA (SENM) members to fix prices and to refuse to deal with payors except on collectively...

Pages